Iron, Neuroinflammation and Neurodegeneration by Roberta J. Ward, David T. Dexter, Robert R. Crichton

Get full text

Is Chelation Therapy a Potential Treatment for Parkinson’s Disease? by Roberta J. Ward, David T. Dexter, Antonio Martin-Bastida, Robert R. Crichton

Get full text

Neuroprotective role for RORA in Parkinson’s disease revealed by analysis of post-mortem brain and a dopaminergic cell line by Felwah S. Al-Zaid, Michael J. Hurley, David T. Dexter, Glenda E. Gillies

Get full text

Mean expression of the X chromosome is associated with neuronal density by James Thomas Swingland, Pascal F Durrenberger, Richard eReynolds, David T Dexter, Ana ePombo, Manuel eDeprez, Federico eRoncaroli, Federico E. Turkheimer

Get full text

A novel approach to high-grade carotid stenosis with concomitant extracranial carotid aneurysms using transcarotid artery revascularization by Michael A. Corbin, BS, Fanny S. Alie-Cusson, MD, David J. Dexter, MD, Animesh Rathore, MD, Rasesh M. Shah, MD, Jean M. Panneton, MD

Get full text

Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease by Antonio Martin-Bastida, Roberta J. Ward, Rexford Newbould, Paola Piccini, David Sharp, Christina Kabba, Maneesh C. Patel, Michael Spino, John Connelly, Fernando Tricta, Robert R. Crichton, David T. Dexter

Get full text

Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease by Klaus Romero, Daniela Conrado, Jackson Burton, Timothy Nicholas, Vikram Sinha, Sreeraj Macha, Malidi Ahamadi, Jesse Cedarbaum, John Seibyl, Kenneth Marek, Peter Basseches, Derek Hill, Ed Somer, Jill Gallagher, David T. Dexter, Arthur Roach, Diane Stephenson, for the Critical Path for Parkinson's (CPP) Consortium, the Parkinson's Progression Markers Initiative (PPMI)

Get full text